Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.02
HCA's Cash to Debt is ranked lower than
91% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.31 vs. HCA: 0.02 )
Ranked among companies with meaningful Cash to Debt only.
HCA' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.02 Max: N/A
Current: 0.02
Equity to Asset -0.23
HCA's Equity to Asset is ranked lower than
95% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HCA: -0.23 )
Ranked among companies with meaningful Equity to Asset only.
HCA' s Equity to Asset Range Over the Past 10 Years
Min: -0.5  Med: 0.22 Max: 0.42
Current: -0.23
-0.5
0.42
Interest Coverage 3.57
HCA's Interest Coverage is ranked lower than
73% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 9.36 vs. HCA: 3.57 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.32  Med: 2.13 Max: 4.43
Current: 3.57
1.32
4.43
F-Score: 8
Z-Score: 2.04
M-Score: -2.79
WACC vs ROIC
3.84%
18.72%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.96
HCA's Operating margin (%) is ranked higher than
79% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. HCA: 14.96 )
Ranked among companies with meaningful Operating margin (%) only.
HCA' s Operating margin (%) Range Over the Past 10 Years
Min: 8.62  Med: 12.26 Max: 15.86
Current: 14.96
8.62
15.86
Net-margin (%) 5.37
HCA's Net-margin (%) is ranked higher than
59% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. HCA: 5.37 )
Ranked among companies with meaningful Net-margin (%) only.
HCA' s Net-margin (%) Range Over the Past 10 Years
Min: 2.37  Med: 4.43 Max: 7.58
Current: 5.37
2.37
7.58
ROA (%) 6.70
HCA's ROA (%) is ranked higher than
66% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. HCA: 6.70 )
Ranked among companies with meaningful ROA (%) only.
HCA' s ROA (%) Range Over the Past 10 Years
Min: 2.79  Med: 5.25 Max: 9.71
Current: 6.7
2.79
9.71
ROC (Joel Greenblatt) (%) 31.15
HCA's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 20.18 vs. HCA: 31.15 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
HCA' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 19.55  Med: 29.26 Max: 37.66
Current: 31.15
19.55
37.66
Revenue Growth (3Y)(%) 7.70
HCA's Revenue Growth (3Y)(%) is ranked lower than
53% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. HCA: 7.70 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
HCA' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -7.8  Med: 6.30 Max: 24.3
Current: 7.7
-7.8
24.3
EBITDA Growth (3Y)(%) 3.20
HCA's EBITDA Growth (3Y)(%) is ranked lower than
70% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. HCA: 3.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
HCA' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.9  Med: 6.55 Max: 39.3
Current: 3.2
-9.9
39.3
EPS Growth (3Y)(%) -5.70
HCA's EPS Growth (3Y)(%) is ranked lower than
75% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. HCA: -5.70 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
HCA' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: 9.80 Max: 88.4
Current: -5.7
0
88.4
» HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

HCA Guru Trades in Q1 2015

Robert Olstein 62,000 sh (New)
Caxton Associates 15,000 sh (New)
David Dreman 28,963 sh (New)
Mario Gabelli 25,000 sh (+25.00%)
Vanguard Health Care Fund 7,075,900 sh (+15.18%)
Pioneer Investments 619,170 sh (+12.18%)
Steve Mandel 5,836,872 sh (unchged)
John Paulson 4,711,900 sh (unchged)
Steven Cohen Sold Out
Leon Cooperman Sold Out
Jim Simons Sold Out
First Eagle Investment Sold Out
David Tepper 4,906,582 sh (-2.08%)
Larry Robbins 5,178,678 sh (-16.18%)
Lee Ainslie 874,177 sh (-73.39%)
Andreas Halvorsen 1,016,617 sh (-73.74%)
Louis Moore Bacon 5,870 sh (-78.70%)
Paul Tudor Jones 10,532 sh (-92.88%)
» More
Q2 2015

HCA Guru Trades in Q2 2015

John Burbank 61,554 sh (New)
Jim Simons 64,100 sh (New)
Joel Greenblatt 25,396 sh (New)
Steven Cohen 7,100 sh (New)
Louis Moore Bacon 123,119 sh (+1997.43%)
Paul Tudor Jones 34,599 sh (+228.51%)
Vanguard Health Care Fund 7,647,300 sh (+8.08%)
Mario Gabelli 27,000 sh (+8.00%)
Larry Robbins 5,178,578 sh (unchged)
John Paulson 4,711,900 sh (unchged)
Caxton Associates Sold Out
Andreas Halvorsen Sold Out
Lee Ainslie Sold Out
David Dreman 28,337 sh (-2.16%)
Steve Mandel 5,007,242 sh (-14.21%)
David Tepper 4,184,525 sh (-14.72%)
Robert Olstein 49,000 sh (-20.97%)
Pioneer Investments 165,368 sh (-73.29%)
» More
Q3 2015

HCA Guru Trades in Q3 2015

John Hussman 75,000 sh (New)
Jim Simons 516,400 sh (+705.62%)
Vanguard Health Care Fund 10,184,243 sh (+33.17%)
Larry Robbins 5,513,278 sh (+6.46%)
Mario Gabelli 27,225 sh (+0.83%)
John Paulson 4,711,900 sh (unchged)
Robert Olstein Sold Out
John Burbank Sold Out
Louis Moore Bacon Sold Out
Steve Mandel Sold Out
Joel Greenblatt Sold Out
Steven Cohen Sold Out
David Dreman 25,802 sh (-8.95%)
David Tepper 3,553,537 sh (-15.08%)
Pioneer Investments 56,819 sh (-65.64%)
Paul Tudor Jones 7,800 sh (-77.46%)
» More
Q4 2015

HCA Guru Trades in Q4 2015

Vanguard Health Care Fund 11,911,153 sh (+16.96%)
Mario Gabelli 27,800 sh (+2.11%)
John Hussman Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about HCA Holdings Inc

An Overview of Appaloosa Management's Top 3 Holdings Analysis of David Tepper's top stocks and a general overview of growth rates and performance metrics on each
David Tepper (Trades, Portfolio) runs Appaloosa Management LP, a $2.9 billion hedge fund. It's important to analyze key holdings from prominent hedge funds because they have more analytical resources to analyze stocks than the majority of individual investors. Here is a look at Appaloosa's most interesting stock selections: Read more...
Steve Mandel Closes Position in Lowe's Lone Pine Capital founder's largest sales in the 3rd quarter
Steve Mandel (Trades, Portfolio) is the founder of Lone Pine Capital, a long/short equity money manager that he started in 1997. The firm uses fundamental analysis and bottom up stock picking to build the portfolio. Mandel uses both value and growth methodologies, and does not hold many stocks for very long. Read more...
Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Its largest trades include Merck, HCA, Baxter
Edward Owens has worked in investment management for more than 30 years. He has managed the Vanguard Health Care Fund (Trades, Portfolio) since its inception in May 1984. The hedge fund has a portfolio composed of 82 stocks with a total value of $46,362 million and the following are the most weighted trades based on the impact on the portfolio during the third quarter. Read more...
David Tepper's Five Most Heavily Weighted Holdings General Motors, Apple are at the top of the list
If David Tepper (Trades, Portfolio) slips under some financial observers’ radars, he shouldn’t. At the end of the second quarter, Tepper, the founder of Appaloosa Management LP, was worth $10.7 billion and owned shares in 35 companies with a value of more than $4 billion. Read more...
Steve Mandel Buys Visa, DaVita Healthcare In Q4
Steve Mandel (Trades, Portfolio) founded hedge fund Lone Pine Capital in 1997, which employs a bottom-up stock picking strategy. Using both value and growth strategies, Mandel tends not to hold stocks for very long. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 14.50
HCA's P/E(ttm) is ranked higher than
88% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. HCA: 14.50 )
Ranked among companies with meaningful P/E(ttm) only.
HCA' s P/E(ttm) Range Over the Past 10 Years
Min: 3.87  Med: 14.04 Max: 19.7
Current: 14.5
3.87
19.7
Forward P/E 10.24
HCA's Forward P/E is ranked higher than
85% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 16.75 vs. HCA: 10.24 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 14.50
HCA's PE(NRI) is ranked higher than
87% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 24.85 vs. HCA: 14.50 )
Ranked among companies with meaningful PE(NRI) only.
HCA' s PE(NRI) Range Over the Past 10 Years
Min: 3.87  Med: 14.06 Max: 19.72
Current: 14.5
3.87
19.72
P/S 0.77
HCA's P/S is ranked higher than
70% of the 301 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. HCA: 0.77 )
Ranked among companies with meaningful P/S only.
HCA' s P/S Range Over the Past 10 Years
Min: 0.31  Med: 0.56 Max: 1.06
Current: 0.77
0.31
1.06
PFCF 11.89
HCA's PFCF is ranked higher than
80% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. HCA: 11.89 )
Ranked among companies with meaningful PFCF only.
HCA' s PFCF Range Over the Past 10 Years
Min: 4.08  Med: 11.41 Max: 17.2
Current: 11.89
4.08
17.2
POCF 6.26
HCA's POCF is ranked higher than
87% of the 275 Companies
in the Global Medical Care industry.

( Industry Median: 14.09 vs. HCA: 6.26 )
Ranked among companies with meaningful POCF only.
HCA' s POCF Range Over the Past 10 Years
Min: 2.57  Med: 5.18 Max: 8.48
Current: 6.26
2.57
8.48
EV-to-EBIT 10.59
HCA's EV-to-EBIT is ranked higher than
90% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HCA: 10.59 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.70 Max: 12.6
Current: 10.59
6.3
12.6
EV-to-EBITDA 7.91
HCA's EV-to-EBITDA is ranked higher than
87% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 12.05 vs. HCA: 7.91 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.80 Max: 9.4
Current: 7.91
5
9.4
PEG 3.82
HCA's PEG is ranked lower than
66% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. HCA: 3.82 )
Ranked among companies with meaningful PEG only.
HCA' s PEG Range Over the Past 10 Years
Min: 0.43  Med: 0.95 Max: 10.84
Current: 3.82
0.43
10.84
Shiller P/E 17.12
HCA's Shiller P/E is ranked higher than
81% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 27.95 vs. HCA: 17.12 )
Ranked among companies with meaningful Shiller P/E only.
HCA' s Shiller P/E Range Over the Past 10 Years
Min: 6.12  Med: 11.45 Max: 23.25
Current: 17.12
6.12
23.25
Current Ratio 1.46
HCA's Current Ratio is ranked higher than
59% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. HCA: 1.46 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 0.81  Med: 1.51 Max: 1.9
Current: 1.46
0.81
1.9
Quick Ratio 1.24
HCA's Quick Ratio is ranked higher than
51% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. HCA: 1.24 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.33 Max: 1.68
Current: 1.24
0.71
1.68
Days Inventory 74.03
HCA's Days Inventory is ranked lower than
89% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 16.67 vs. HCA: 74.03 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 52.77  Med: 60.10 Max: 71.64
Current: 74.03
52.77
71.64
Days Sales Outstanding 54.17
HCA's Days Sales Outstanding is ranked lower than
61% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 45.70 vs. HCA: 54.17 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 51.28 Max: 56.3
Current: 54.17
44.84
56.3
Days Payable 119.32
HCA's Days Payable is ranked higher than
77% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. HCA: 119.32 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 108.24  Med: 112.98 Max: 131.28
Current: 119.32
108.24
131.28

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 2.27
HCA's Price/Projected FCF is ranked lower than
74% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. HCA: 2.27 )
Ranked among companies with meaningful Price/Projected FCF only.
HCA' s Price/Projected FCF Range Over the Past 10 Years
Min: 2.54  Med: 4.34 Max: 29.58
Current: 2.27
2.54
29.58
Price/DCF (Earnings Based) 1.85
HCA's Price/DCF (Earnings Based) is ranked lower than
77% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 1.54 vs. HCA: 1.85 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.37
HCA's Price/Median PS Value is ranked lower than
71% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. HCA: 1.37 )
Ranked among companies with meaningful Price/Median PS Value only.
HCA' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.6  Med: 1.01 Max: 1.85
Current: 1.37
0.6
1.85
Price/Peter Lynch Fair Value 2.70
HCA's Price/Peter Lynch Fair Value is ranked lower than
54% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. HCA: 2.70 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
HCA' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.44  Med: 0.88 Max: 3.66
Current: 2.7
0.44
3.66
Earnings Yield (Greenblatt) (%) 9.40
HCA's Earnings Yield (Greenblatt) (%) is ranked higher than
90% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. HCA: 9.40 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
HCA' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 8  Med: 9.40 Max: 16
Current: 9.4
8
16
Forward Rate of Return (Yacktman) (%) 12.12
HCA's Forward Rate of Return (Yacktman) (%) is ranked higher than
55% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 10.04 vs. HCA: 12.12 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
HCA' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -10.4  Med: 7.10 Max: 40.6
Current: 12.12
-10.4
40.6

More Statistics

Revenue(Mil) $39678
EPS $ 4.78
Beta0.23
Short Percentage of Float2.93%
52-Week Range $43.91 - 95.49
Shares Outstanding(Mil)407.67

Analyst Estimate

Dec15 Dec16 Dec17 Dec18
Revenue(Mil) 33,170 42,875 45,534 51,184
EPS($) 5.29 5.99 6.63 7.15
EPS without NRI($) 5.29 5.99 6.63 7.15

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 166 hospitals, comprised of 162 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operated 113 freestanding surgery centers. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.
» More Articles for HCA

Headlines

Articles On GuruFocus.com
An Overview of Appaloosa Management's Top 3 Holdings Dec 24 2015 
Steve Mandel Closes Position in Lowe's Dec 10 2015 
Tepper Boosts Stake in TerraForm Power, Increases Pressure on Board Dec 08 2015 
Vanguard Raises Stakes in Biogen, Mylan, Merck Nov 15 2015 
Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer Nov 02 2015 
David Tepper's Five Most Heavily Weighted Holdings Oct 12 2015 
Obamacare Makes HCA a Buy Aug 24 2015 
Weekly CEO Sells Highlight: Netlist Inc, Amphastar Pharmaceuticals Inc, G-III Apparel Group Ltd, and Jun 14 2015 
The Olstein All Cap Value Fund’s Q1 2015 Letter to Shareholders May 28 2015 
Weekly Insider Sells Highlight: VRX, HCA, GPRO, GD May 11 2015 

More From Other Websites
HCA Holdings Had Solid Inpatient and Outpatient Revenue Growth Feb 05 2016
HCA HOLDINGS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 05 2016
HCA Holdings’s Operating Expense Ratio Fell in 4Q15 Feb 05 2016
What Boosted HCA Holdings’s Revenue in 4Q15? Feb 04 2016
HCA Holdings, Inc. Earnings Analysis: 2015 By the Numbers Feb 04 2016
The One Stock I Would Consider Buying In This Market Feb 04 2016
HCA Holdings, Mastercard, GoPro, Transocean and Vornado Realty Trust highlighted as Zacks Bull and... Feb 03 2016
Bull of the Day: HCA Holdings (HCA) Feb 03 2016
Urgent Care Market Braces For CVS And Walgreens Entry Feb 03 2016
The C-Suite Speaks: Business as Usual? Feb 02 2016
HCA Holdings’s 4Q15 Earnings: What Investors Should Know Feb 02 2016
Bundled Payments Are Coming To Joint Replacement Surgery Feb 01 2016
Orlando Health sees multimillion-dollar boost in net income Jan 29 2016
HCA Stock Price Target Raised at Credit Suisse Jan 29 2016
Heres what CEOs said on this week’s earnings calls Jan 29 2016
Why Earnings Season Could Be Great for HCA Holdings (HCA) Jan 29 2016
HCA's Urgent Care Buying Binge Pays Off Jan 29 2016
Edited Transcript of HCA earnings conference call or presentation 28-Jan-16 3:00pm GMT Jan 28 2016
HCA rebounds strong in fourth quarter, assures investors all is well Jan 28 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK